Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-011195
Filing Date
2017-11-01
Accepted
2017-11-01 16:39:41
Documents
1
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4103117slager_oramedpharm.html 4  
1 OWNERSHIP DOCUMENT f4103117slager_oramedpharm.xml 4 6703
  Complete submission text file 0001213900-17-011195.txt   8343
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Reporting) CIK: 0001477733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 171169467